{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:01:08Z","timestamp":1781704868096,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s12325-009-0011-z","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T17:50:45Z","timestamp":1238435445000},"page":"281-294","source":"Crossref","is-referenced-by-count":42,"title":["Teratogenesis associated with antibipolar agents"],"prefix":"10.1007","volume":"26","author":[{"given":"Ha T. T.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verinder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,28]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"R.C. Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA. 2003;289:3095\u20133105.","journal-title":"JAMA"},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","volume":"17","author":"L. Tondo","year":"2003","unstructured":"Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17:491\u2013511.","journal-title":"CNS Drugs"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","volume":"349","author":"C.J. Murray","year":"1997","unstructured":"Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1436\u20131442.","journal-title":"Lancet"},{"key":"11_CR4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition Text revision (DSM-IV-TR)","author":"American Psychiatric Association.","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edition Text revision (DSM-IV-TR). 4th edition. Washington: American Psychiatric Association; 2000.","edition":"4th edition"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10401230701653377","volume":"19","author":"R.S. McIntyre","year":"2007","unstructured":"McIntyre RS, Soczynska JK, Konarski JZ, et al. Should depressive syndromes be reclassified as \u201cMetabolic Syndrome Type II\u201d? Ann Clin Psychiatry. 2007;19:257\u2013264.","journal-title":"Ann Clin Psychiatry"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900028844","volume":"9","author":"R.S. McIntyre","year":"2004","unstructured":"McIntyre RS, Konarski JZ. Bipolar disorder: a national health concern. CNS Spectr. 2004;9:6\u201315.","journal-title":"CNS Spectr"},{"key":"11_CR7","first-page":"235","volume":"27","author":"R. McIntyre","year":"2002","unstructured":"McIntyre R, Kennedy S, Bagby RM, Bakish D. Assessing full remission. J Psychiatry Neurosci. 2002;27:235\u2013239.","journal-title":"J Psychiatry Neurosci"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","volume":"164","author":"A.C. Viguera","year":"2007","unstructured":"Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164:1817\u20131824.","journal-title":"Am J Psychiatry"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2007.68.10.27323","volume":"68","author":"J.P. Pandarakalam","year":"2007","unstructured":"Pandarakalam JP. Clinical challenges of bipolar depression. Br J Hosp Med (Lond). 2007;68:530\u2013537.","journal-title":"Br J Hosp Med (Lond)"},{"key":"11_CR10","first-page":"42","volume":"63suppl.4","author":"C.L. Ernst","year":"2002","unstructured":"Ernst CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry. 2002;63(suppl. 4):42\u201355.","journal-title":"J Clin Psychiatry"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","volume":"161","author":"K.A. Yonkers","year":"2004","unstructured":"Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004;161:608\u2013620.","journal-title":"Am J Psychiatry"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","volume":"8","author":"L.N. Yatham","year":"2006","unstructured":"Yatham LN, Kennedy SH, O\u2019Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8:721\u2013739.","journal-title":"Bipolar Disord"},{"key":"11_CR13","first-page":"29","volume":"68suppl.9","author":"A.C. Viguera","year":"2007","unstructured":"Viguera AC, Koukopoulos A, Muzina DJ, et al. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry. 2007;68(suppl. 9):29\u201333.","journal-title":"J Clin Psychiatry"},{"key":"11_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1176\/appi.ajp.159.1.136","volume":"159","author":"G. Koren","year":"2002","unstructured":"Koren G, Cohn T, Chitayat D, et al. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry. 2002;159:136\u2013137.","journal-title":"Am J Psychiatry"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","volume":"67","author":"K.J. Meador","year":"2006","unstructured":"Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006;67:407\u2013412.","journal-title":"Neurology"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","volume":"93","author":"K. Wide","year":"2004","unstructured":"Wide K, Winbladh B, Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr. 2004;93:174\u2013176.","journal-title":"Acta Paediatr"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1399-5618.2003.00089.x","volume":"6","author":"V.K. Burt","year":"2004","unstructured":"Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord. 2004;6:2\u201313.","journal-title":"Bipolar Disord"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","volume":"77","author":"J. Morrow","year":"2006","unstructured":"Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77:193\u2013198.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(98)00084-9","volume":"33","author":"S. Kaneko","year":"1999","unstructured":"Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999;33:145\u2013158.","journal-title":"Epilepsy Res"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","volume":"60","author":"E. Kaaja","year":"2003","unstructured":"Kaaja E, Kaaja R, Hiilesmaa V. Major malformations in offspring of women with epilepsy. Neurology. 2003;60:575\u2013579.","journal-title":"Neurology"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","volume":"64","author":"M. Artama","year":"2005","unstructured":"Artama M, Auvinen A, Raudaskoski T, et al. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology. 2005;64:1874\u20131878.","journal-title":"Neurology"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0967-5868(03)00158-9","volume":"10","author":"F.J. Vajda","year":"2003","unstructured":"Vajda FJ, O\u2019Brien TJ, Hitchcock, A et al. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. J Clin Neurosci. 2003;10:543\u2013549.","journal-title":"J Clin Neurosci"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","volume":"64","author":"D.F. Wyszynski","year":"2005","unstructured":"Wyszynski DF, Nambisan M, Surve T, et al. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64:961\u2013965.","journal-title":"Neurology"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2005.00458.x","volume":"112","author":"F.J. Vajda","year":"2005","unstructured":"Vajda FJ, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol Scand. 2005;112:137\u2013143.","journal-title":"Acta Neurol Scand"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2004.05.003","volume":"11","author":"F.J. Vajda","year":"2004","unstructured":"Vajda FJ, O\u2019Brien TJ, Hitchcock A, et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci. 2004;11:854\u2013858.","journal-title":"J Clin Neurosci"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-1331.2006.01359.x","volume":"13","author":"F.J. Vajda","year":"2006","unstructured":"Vajda FJ, Hitchcock A, Graham J, et al. Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol. 2006;13:645\u2013654.","journal-title":"Eur J Neurol"},{"key":"11_CR27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","volume":"64","author":"M. Cunnington","year":"2005","unstructured":"Cunnington M, Tennis P. Lamotrigine and the risk of malformations in pregnancy. Neurology. 2005;64:955\u2013960.","journal-title":"Neurology"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","volume":"344","author":"L.B. Holmes","year":"2001","unstructured":"Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001;344:1132\u20131138.","journal-title":"N Engl J Med"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2","volume":"46","author":"E.B. Samren","year":"1999","unstructured":"Samren EB, van Duijn CM, Christiaens GC, et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol. 1999;46:739\u2013746.","journal-title":"Ann Neurol"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1528-1157.1999.tb00851.x","volume":"40","author":"R. Canger","year":"1999","unstructured":"Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia. 1999;40:1231\u20131236.","journal-title":"Epilepsia"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","volume":"70","author":"N. Adab","year":"2001","unstructured":"Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2001;70:15\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11_CR32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","volume":"271","author":"L.S. Cohen","year":"1994","unstructured":"Cohen LS, Friedman JM, Jefferson JW, et al. A reevaluation of risk of in utero exposure to lithium. JAMA. 1994;271:146\u2013150.","journal-title":"JAMA"},{"key":"11_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bmj.2.5859.135","volume":"2","author":"M. Schou","year":"1973","unstructured":"Schou M, Goldfield MD, Weinstein MR, et al. Lithium and pregnancy. I. Report from the Register of Lithium Babies. Br Med J. 1973;2:135\u2013136.","journal-title":"Br Med J."},{"key":"11_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","volume":"66","author":"K. McKenna","year":"2005","unstructured":"McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66:444\u2013449.","journal-title":"J Clin Psychiatry"},{"key":"11_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","volume":"20","author":"D.J. Goldstein","year":"2000","unstructured":"Goldstein DJ, Corbin LA, Fung MC. Olanzapineexposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20:399\u2013403.","journal-title":"J Clin Psychopharmacol"},{"key":"11_CR36","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","volume":"75","author":"N. Adab","year":"2004","unstructured":"Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2004;75:1575\u20131583.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","volume":"64","author":"J. Vinten","year":"2005","unstructured":"Vinten J, Adab N, Kini U, et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology. 2005;64:949\u2013954.","journal-title":"Neurology"},{"key":"11_CR38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","volume":"62","author":"E. Gaily","year":"2004","unstructured":"Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology. 2004;62:28\u201332.","journal-title":"Neurology"},{"key":"11_CR39","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.1998.tb01186.x","volume":"39","author":"E. Olafsson","year":"1998","unstructured":"Olafsson E, Hallgrimsson JT, Hauser WA, et al. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia. 1998;39:887\u2013892.","journal-title":"Epilepsia"},{"key":"11_CR40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.seizure.2007.11.016","volume":"17","author":"T. Tomson","year":"2008","unstructured":"Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Seizure. 2008;17:166\u2013171.","journal-title":"Seizure"},{"key":"11_CR41","first-page":"57","volume":"59suppl.6","author":"A. Llewellyn","year":"1998","unstructured":"Llewellyn A, Stowe ZN, Strader JR Jr. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry. 1998;59(suppl. 6):57\u201364.","journal-title":"J Clin Psychiatry"},{"key":"11_CR42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0193-953X(03)00046-7","volume":"26","author":"R. Nonacs","year":"2003","unstructured":"Nonacs R, Cohen LS. Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am. 2003;26:547\u2013562.","journal-title":"Psychiatr Clin North Am"},{"key":"11_CR43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM198906223202505","volume":"320","author":"K.L. Jones","year":"1989","unstructured":"Jones KL, Lacro RV, Johnson KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med. 1989;320:1661\u20131666.","journal-title":"N Engl J Med"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/009286157601000210","volume":"10","author":"M.R. Weinstein","year":"1976","unstructured":"Weinstein MR. The international register of lithium babies. Drug Inf J. 1976;10:94\u2013100.","journal-title":"Drug Inf J"},{"key":"11_CR45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","volume":"19","author":"J.H. DiLiberti","year":"1984","unstructured":"DiLiberti JH, Farndon PA, Dennis NR, et al. The fetal valproate syndrome. Am J Med Genet. 1984;19:473\u2013481.","journal-title":"Am J Med Genet"},{"key":"11_CR46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","volume":"38","author":"F.J. Mackay","year":"1997","unstructured":"Mackay FJ, Wilton LV, Pearce GL, et al. Safety of long-term lamotrigine in epilepsy. Epilepsia. 1997;38:881\u2013886.","journal-title":"Epilepsia"},{"key":"11_CR47","volume-title":"Compendium of Pharmaceuticals and Specialties","author":"CPS.","year":"2007","unstructured":"CPS. Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacist Association; 2007."},{"key":"11_CR48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0892-0362(92)90050-K","volume":"14","author":"J.G. Auerbach","year":"1992","unstructured":"Auerbach JG, Hans SL, Marcus J, et al. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol. 1992;14:399\u2013406.","journal-title":"Neurotoxicol Teratol"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4088\/JCP.v63n0114c","volume":"63","author":"T. Ratnayake","year":"2002","unstructured":"Ratnayake T, Libretto SE. No complications with risperidone treatment before and throughout pregnancy and during the nursing period. J Clin Psychiatry. 2002;63:76\u201377.","journal-title":"J Clin Psychiatry"},{"key":"11_CR50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1469-8749.2007.02020.x","volume":"50","author":"K. Titze","year":"2008","unstructured":"Titze K, Koch S, Helge H, et al. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol. 2008;50:117\u2013122.","journal-title":"Dev Med Child Neurol"},{"key":"11_CR51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","volume":"37","author":"S.J. Moore","year":"2000","unstructured":"Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37:489\u2013497.","journal-title":"J Med Genet"},{"key":"11_CR52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","volume":"47","author":"A.D. Rasalam","year":"2005","unstructured":"Rasalam AD, Hailey H, Williams JH, et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol. 2005;47:551\u2013555.","journal-title":"Dev Med Child Neurol"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","volume":"39","author":"P.G. Williams","year":"1997","unstructured":"Williams PG, Hersh JH. A male with fetal valproate syndrome and autism. Dev Med Child Neurol. 1997;39:632\u2013634.","journal-title":"Dev Med Child Neurol"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.61.6_suppl_2.S23","volume":"616suppl.2","author":"M.S. Yerby","year":"2003","unstructured":"Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology. 2003;61(6 suppl. 2):S23\u2013S26.","journal-title":"Neurology"},{"key":"11_CR55","first-page":"339","volume":"34","author":"A.C. Viguera","year":"1998","unstructured":"Viguera AC, Cohen LS. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull. 1998;34:339\u2013346.","journal-title":"Psychopharmacol Bull"},{"key":"11_CR56","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0890-6238(94)90003-5","volume":"8","author":"A.J. Kallen","year":"1994","unstructured":"Kallen AJ. Maternal carbamazepine and infant spina bifida. Reprod Toxicol. 1994;8:203\u2013205.","journal-title":"Reprod Toxicol"},{"key":"11_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","volume":"16","author":"S. Matalon","year":"2002","unstructured":"Matalon S, Schechtman S, Goldzweig G, et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol. 2002;16:9\u201317.","journal-title":"Reprod Toxicol"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U","volume":"68","author":"I. Nulman","year":"1997","unstructured":"Nulman I, Scolnik D, Chitayat D, et al. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet. 1997;68:18\u201324.","journal-title":"Am J Med Genet"},{"key":"11_CR59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM199103073241006","volume":"324","author":"F.W. Rosa","year":"1991","unstructured":"Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324:674\u2013677.","journal-title":"N Engl J Med"},{"key":"11_CR60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.57.2.321","volume":"57","author":"O. av-Citrin","year":"2001","unstructured":"av-Citrin O, Shechtman S, Arnon J, et al. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology. 2001;57:321\u2013324.","journal-title":"Neurology"},{"key":"11_CR61","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00007611-200194030-00007","volume":"94","author":"M.M. Iqbal","year":"2001","unstructured":"Iqbal MM, Gundlapalli SP, Ryan WG, et al. Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South Med J. 2001;94:304\u2013322.","journal-title":"South Med J"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpeds.2004.08.048","volume":"146","author":"L.B. Holmes","year":"2005","unstructured":"Holmes LB, Coull BA, Dorfman J, et al. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr. 2005;146:118\u2013122.","journal-title":"J Pediatr"},{"key":"11_CR63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-5618.2006.00295.x","volume":"8","author":"S. Gentile","year":"2006","unstructured":"Gentile S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 2006;8:207\u2013220.","journal-title":"Bipolar Disord"},{"key":"11_CR64","first-page":"880","volume":"48","author":"P. L. Prakash","year":"2007","unstructured":"Prakash, Prabhu LV, Nasar MA, et al. Lamotrigine in pregnancy: safety profile and the risk of malformations. Singapore Med J. 2007;48:880\u2013883.","journal-title":"Singapore Med J"},{"key":"11_CR65","first-page":"1007","volume":"53","author":"S. Shor","year":"2007","unstructured":"Shor S, Koren G, Nulman I. Teratogenicity of lamotrigine. Can Fam Physician. 2007;53:1007\u20131009.","journal-title":"Can Fam Physician"},{"key":"11_CR66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1399-5618.2007.00565.x","volume":"10","author":"D.J. Newport","year":"2008","unstructured":"Newport DJ, Stowe ZN, Viguera AC, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord. 2008;10:432\u2013436.","journal-title":"Bipolar Disord"},{"key":"11_CR67","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","volume":"162","author":"D.J. Newport","year":"2005","unstructured":"Newport DJ, Viguera AC, Beach AJ, et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry. 2005;162:2162\u20132170.","journal-title":"Am J Psychiatry"},{"key":"11_CR68","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","volume":"164","author":"D.J. Newport","year":"2007","unstructured":"Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164:1214\u20131220.","journal-title":"Am J Psychiatry"},{"key":"11_CR69","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1399-5618.2007.00491.x","volume":"9","author":"S. Dube","year":"2007","unstructured":"Dube S, Tollefson GD, Thase ME, et al. Onset of antidepressant effect of olanzapine and olanzapine\/fluoxetine combination in bipolar depression. Bipolar Disord. 2007;9:618\u2013627.","journal-title":"Bipolar Disord"},{"key":"11_CR70","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","volume":"356","author":"S. Alwan","year":"2007","unstructured":"Alwan S, Reefhuis J, Rasmussen SA, et al. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356:2684\u20132692.","journal-title":"N Engl J Med"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","volume":"356","author":"C. Louik","year":"2007","unstructured":"Louik C, Lin AE, Werler MM, et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356:2675\u20132683.","journal-title":"N Engl J Med"},{"key":"11_CR72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1517\/14740338.7.2.195","volume":"7","author":"M.J. Eadie","year":"2008","unstructured":"Eadie MJ. Antiepileptic drugs as human teratogens. Expert Opin Drug Saf. 2008;7:195\u2013209.","journal-title":"Expert Opin Drug Saf"},{"key":"11_CR73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","volume":"27","author":"S. Fried","year":"2004","unstructured":"Fried S, Kozer E, Nulman I, et al. Malformation rates in children of women with untreated epilepsy: a meta-analysis. Drug Saf. 2004;27:197\u2013202.","journal-title":"Drug Saf"},{"key":"11_CR74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.157.2.179","volume":"157","author":"A.C. Viguera","year":"2000","unstructured":"Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179\u2013184.","journal-title":"Am J Psychiatry"},{"key":"11_CR75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","volume":"38","author":"E.B. Samren","year":"1997","unstructured":"Samren EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia. 1997;38:981\u2013990.","journal-title":"Epilepsia"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/070674370104600308","volume":"46","author":"R.S. McIntyre","year":"2001","unstructured":"McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry. 2001;46:273\u2013281.","journal-title":"Can J Psychiatry"},{"key":"11_CR77","first-page":"15","volume":"63suppl.3","author":"R.S. McIntyre","year":"2002","unstructured":"McIntyre RS. Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. J Clin Psychiatry. 2002;63(suppl. 3):15\u201320.","journal-title":"J Clin Psychiatry"},{"key":"11_CR78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmwh.2006.09.002","volume":"52","author":"S. Ward","year":"2007","unstructured":"Ward S, Wisner KL. Collaborative management of women with bipolar disorder during pregnancy and postpartum: pharmacologic considerations. J Midwifery Womens Health. 2007;52:3\u201313.","journal-title":"J Midwifery Womens Health"},{"key":"11_CR79","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.2337\/dc07-s224","volume":"30suppl.2","author":"M.W. Carpenter","year":"2007","unstructured":"Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care. 2007;30(suppl. 2):S246\u2013S250.","journal-title":"Diabetes Care"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1019722011688","volume":"6","author":"S.L. Carmichael","year":"2002","unstructured":"Carmichael SL, Shaw GM, Neri E, et al. Physical activity and risk of neural tube defects. Matern Child Health J. 2002;6:151\u2013157.","journal-title":"Matern Child Health J"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s002280050234","volume":"51","author":"B. Rambeck","year":"1997","unstructured":"Rambeck B, Kurlemann G, Stodieck SR, et al. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol. 1997;51:481\u2013484.","journal-title":"Eur J Clin Pharmacol"},{"key":"11_CR82","first-page":"444","volume":"45","author":"L.J. Miller","year":"1994","unstructured":"Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry. 1994;45:444\u2013450.","journal-title":"Hosp Community Psychiatry"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0011-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0011-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:55:54Z","timestamp":1559462154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0011-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}